RESULTS	Thirteen patients receiving TNF ( 68 % ; 95 % CI 47 % to 89 % ) achieved inactive disease , whereas eight ( 40 % ; 95 % CI 22 % to 63 % ) on COMBO and five ( 25 % ; 95 % CI 6 % to 44 % ) on methotrexate did ( p = 0.002 ) .\